A detailed history of Daiwa Securities Group Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 31,594 shares of BIIB stock, worth $4.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
31,594
Previous 24,848 27.15%
Holding current value
$4.91 Million
Previous $5.76 Million 6.32%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $1.28 Million - $1.6 Million
6,746 Added 27.15%
31,594 $6.12 Million
Q2 2024

Aug 07, 2024

BUY
$190.52 - $236.72 $418,572 - $520,073
2,197 Added 9.7%
24,848 $5.76 Million
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $460,507 - $581,466
2,172 Added 10.61%
22,651 $4.88 Million
Q4 2023

Jan 31, 2024

SELL
$222.59 - $267.94 $1.47 Million - $1.77 Million
-6,600 Reduced 24.37%
20,479 $5.3 Million
Q3 2023

Nov 01, 2023

BUY
$253.3 - $285.89 $2.14 Million - $2.41 Million
8,442 Added 45.3%
27,079 $6.87 Million
Q2 2023

Jul 31, 2023

BUY
$275.25 - $318.06 $139,827 - $161,574
508 Added 2.8%
18,637 $5.31 Million
Q1 2023

May 02, 2023

BUY
$256.56 - $292.34 $476,945 - $543,460
1,859 Added 11.43%
18,129 $5.04 Million
Q4 2022

Feb 06, 2023

BUY
$252.44 - $306.72 $105,015 - $127,595
416 Added 2.62%
16,270 $4.51 Million
Q3 2022

Nov 02, 2022

SELL
$194.69 - $268.46 $198,194 - $273,292
-1,018 Reduced 6.03%
15,854 $4.23 Million
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $118,712 - $141,171
633 Added 3.9%
16,872 $3.44 Million
Q1 2022

Apr 29, 2022

BUY
$193.77 - $244.14 $334,640 - $421,629
1,727 Added 11.9%
16,239 $3.42 Million
Q4 2021

Feb 03, 2022

BUY
$223.92 - $287.77 $354,913 - $456,115
1,585 Added 12.26%
14,512 $3.48 Million
Q3 2021

Nov 05, 2021

BUY
$282.99 - $369.05 $193,282 - $252,061
683 Added 5.58%
12,927 $3.66 Million
Q2 2021

Aug 06, 2021

SELL
$259.0 - $414.71 $1.21 Million - $1.94 Million
-4,667 Reduced 27.6%
12,244 $4.24 Million
Q1 2021

May 03, 2021

BUY
$242.95 - $284.63 $1.23 Million - $1.44 Million
5,058 Added 42.67%
16,911 $4.73 Million
Q4 2020

Feb 04, 2021

BUY
$236.26 - $355.63 $6,379 - $9,602
27 Added 0.23%
11,853 $2.9 Million
Q3 2020

Nov 02, 2020

SELL
$264.77 - $305.71 $59,043 - $68,173
-223 Reduced 1.85%
11,826 $3.36 Million
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $222,447 - $294,593
860 Added 7.69%
12,049 $3.77 Million
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $373,970 - $474,386
1,391 Added 14.2%
11,189 $3.54 Million
Q4 2019

Jan 31, 2020

SELL
$220.06 - $304.07 $30,808 - $42,569
-140 Reduced 1.41%
9,798 $2.91 Million
Q3 2019

Nov 04, 2019

BUY
$217.44 - $243.88 $297,457 - $333,627
1,368 Added 15.96%
9,938 $2.31 Million
Q2 2019

Jul 24, 2019

SELL
$219.29 - $241.72 $282,226 - $311,093
-1,287 Reduced 13.06%
8,570 $2 Million
Q1 2019

Apr 26, 2019

SELL
$216.71 - $338.96 $488,897 - $764,693
-2,256 Reduced 18.62%
9,857 $2.33 Million
Q4 2018

Feb 05, 2019

SELL
$278.5 - $352.75 $1.59 Million - $2.01 Million
-5,712 Reduced 32.04%
12,113 $3.65 Million
Q3 2018

Nov 01, 2018

BUY
$293.51 - $383.83 $2.34 Million - $3.06 Million
7,970 Added 80.87%
17,825 $6.3 Million
Q2 2018

Jul 30, 2018

BUY
$257.52 - $306.91 $72,105 - $85,934
280 Added 2.92%
9,855 $2.86 Million
Q1 2018

May 02, 2018

BUY
$260.13 - $367.91 $422,711 - $597,853
1,625 Added 20.44%
9,575 $2.62 Million
Q4 2017

Feb 06, 2018

BUY
$307.64 - $344.58 $44,300 - $49,619
144 Added 1.84%
7,950 $2.53 Million
Q3 2017

Nov 02, 2017

BUY
$281.15 - $329.69 $2.19 Million - $2.57 Million
7,806
7,806 $2.45 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.